The notion that learning and memory processes are highly dependent on central cholinergic neurotransmission has been widely accepted. However, studies documenting the importance of Acetylcholine (ACh) in attention have led some to suggest that attention impairments may underlie the deficits in learning and memory resulting from cholinergic disruptions. Using a visual discrimination task, I attempted to discern whether performance impairments by Scopolamine were predominantly due to the importance of muscarinic receptor integrity in attention, or memory consolidation in learning. Rats were trained in a visual discrimination task using a Y-shaped water maze apparatus. To successfully navigate to a hidden platform located in one of the two goal arms, rats learned to discriminate between 2 distinct visual cues, indicating the platform’s presence (CS+) or absence (CS-), respectively. Following task acquisition, testing continued using a combination of Regular trials (RT; both CS+ and CS- present) and Probe trials (PT; only one of the cues present). Results indicated that performance on PT was impaired due to greater task difficulty under conditions of reduced information, while Scopolamine (1 mg/kg) further impacted PT performance without affecting RTs. In a second experiment, PTs were administered with the platform present to provide reinforcement and a learning opportunity. Animals still exhibited poorer PT performance, but rapidly learned to rely on a single cue for accurate platform localization. Interestingly, this learning was not apparent under conditions of Scopolamine treatment (1 mg/kg), even though RT performance was completely unaffected. To examine experience-dependent changes in neuronal responding after visual discrimination learning, a subset of animals were anesthetised and visual evoked potentials (VEPs) in V1 and area CA1 of the hippocampus were recorded in response to CS+, CS-, and novel stimuli. In both the V1 and CA1, the VEP amplitudes elicited to familiar and novel stimuli were not significantly different. First, these experiments demonstrate the importance of the cholinergic system in sustaining visual attention and acquiring a new single-cue strategy. Furthermore, the null electrophysiology findings do not rule out the plastic response properties of the mature V1 and CA1, but remind us of the complex nature of memory encoding in the brain. / Thesis (Master, Psychology) -- Queen's University, 2011-09-16 13:50:24.045

Spatial navigation is essential for survival not only in mammals. Neural and neuropharmacological changes of learning and memory in humans and rats could be measured through their behavior and responses to stimuli. In focus of experimental models of cognitive deficits, the Morris water maze (MWM) represents a clasiccal test of exact allothetic representation, i.e. the cognitive map. Another important test of spatial navigation is the active place avoidance, or Carousel maze (also AAPA, Active Allothetic Place Avoidance), that can be used to test the ability of cognitive coordination, thus the ability to distinguish relevant stimuli from irrelevant. There are analogous tasks for testing cognitive abilities in humans for both tests (e.g. Blue Velvet Arena for MWM, virtual reality simulations on PC for AAPA, etc.). Aim of the present study is to compare the sensitivity of outbred Long-Evans and Wistar strains of rats from the institutional breeding to the acute administration of scopolamine, the antagonist of central muscarinic acetylcholine receptors, at doses 0.8 mg/kg; 1.5 mg/kg and 3.0 mg/kg. The results show that the Wistar strain is more influenced by cholinergic blockade than Long-Evans strain in both AAPA and the MWM. Furthermore, it appears that the control rat strain Long-Evans have better...

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / Oxidative stress is involved in several neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Oxidative stress seems to be involved in the pathology of dementia/amnesia. It has been suggested that oxidative stress impairs the muscarinic cholinergic system triggering Alzheimer's disease. The muscarinic antagonist scopolamine has been used to induce amnesia in animals. This experimental model has been used in screening anti-amnesic drugs that could be useful for the treatment of dementia. The aim of this study was to evaluate the possible in vitro antioxidant effect of a series of pyrazoline derivatives newly synthesized: (1) 5-hydroxy-3-methyl-5-trifluoromethyl-4,5-dihydro-1H-carbaldehyde-pyrazole, (2) 5-hydroxy-3-methyl-5- trifluoromethyl-4,5-dihydro-1H-1-acetyl-pyrazole, (3) 5-hydroxy-3-methyl-5-trifluoromethyl-4,5-dihydro-1H-carboxyamide-pyrazole, (4) 5-hydroxy-3-methyl-5-trifluoromethyl-4,5-dihydro-1H-1-benzoyl-pyrazole, (5) 5-hydroxy-3-methyl-5-trifluoromethyl-4,5-dihydro-1H-1-(2- hydroxybenzoyl)-pyrazole and (6) 5-hydroxy-3-methyl-5-trifluoromethyl-4,5-dihydro-1H-1-(4-methoxybenzoyl)-pyrazole. Besides, considering the possible involvement of oxidative stress in dementia, the compound that was the most effective in vitro was assessed concerning to its ability to prevent the memory deficit and oxidative stress in a scopolamine-induced amnesia model. Compound (5) had the highest antioxidant capacity in vitro, since it reduced lipid peroxidation (TBARS) basal and stimulated by the pro-oxidants iron, hydrogen peroxide and sodium nitroprusside, having significant effects from 15 μM onwards (p<0.05). Compound (5) also protected against hydrogen peroxide-induced glutathione oxidation, with a significant effect at the concentration of 150 μM (p<0.05). This compound also had the highest total antioxidant activity, demonstrated by its ability to remove the radical 1,1-dyphenyl-2-pycrylhydrazyl (DPPH). Compounds (1) and (4) also reduced lipid peroxidation basal and stimulated by iron and sodium nitroprusside, having significant effects from 15 μM onwards (p<0.05). Compound (2) had the highest ability to reduce iron (p<0.05). Scopolamine administration 30 min before training session resulted in shorter latency to step-down during the test session of the inhibitory avoidance task (p<0.05). Pretreatment with pyrazole compound (5) had no effect per se on the step-down latency. However, pretreatment with compound (5) (100 μmol/kg) 30 min before scopolamine did prevent the amnesic effect of scopolamine (p<0.05). No significant effect of scopolamine or pyrazole treatment was observed on any of the oxidative stress markers evaluated (thiobarbituric acid reactive substances, non-protein sulfhydrylic groups content and activity of enzymes superoxide dismutase and catalase) suggesting that the protective effect of compound (5) was not related to a possible antioxidant activity. Results revealed that pyrazole compound (5) has in vitro antioxidant activity as well as neuroprotective activity in a model of amnesia. These findings suggest that compound (5) could be a promising drug for the treatment of Alzheimer´s disease. However, further studies are needed to elucidate the mechanisms involved in the antiamnesic effect of this compound, as well as its effect on other dementia models. / O estresse oxidativo está envolvido em diversas doenças neurodegenerativas importantes, tais como a doença de Alzheimer, a doença de Parkinson e a esclerose lateral amiotrófica. O estresse oxidativo parece estar envolvido na patologia da demência/amnésia, tendo sido sugerido que as alterações cerebrais decorrentes deste causam danos ao sistema colinérgico muscarínico e que desta forma desencadeiam a doença de Alzheimer. A escopolamina, um antagonista muscarínico, tem sido usado para induzir amnésia em animais, em um modelo experimental para a triagem de drogas que poderiam ser úteis no tratamento da demência. O principal objetivo deste estudo foi avaliar o possível efeito antioxidante in vitro de uma série de derivados pirazolínicos recém sintetizados: (1) 5-hidroxi-3-metil-5-trifluorometil-4,5-diidro-1H-carbaldeido-pirazol, (2) 5-hidroxi-3-metil-5- trifluorometil-4,5-diidro-1H-1-acetil-pirazol, (3) 5-hidroxi-3-metil-5-trifluorometil-4,5-diidro-1Hcarboxiamida- pirazol, (4) 5-hidroxi-3-metil-5-trifluorometil-4,5-diidro-1H-1-benzoil-pirazol, (5) 5-hidroxi-3-metil-5-trifluorometil-4,5-diidro-1H-1-(2-hidroxibenzoil)-pirazol e (6) 5-hidroxi-3-metil-5-trifluorometil-4,5-diidro-1H-1-(4-methoxibenzoil)-pirazol. Além disso, considerando o possível envolvimento do estresse oxidativo na demência, foi avaliada a capacidade do composto mais efetivo in vitro, em prevenir o déficit de memória e o estresse oxidativo em um modelo de amnésia induzida por escopolamina. O derivado pirazolínico (5) apresentou maior capacidade antioxidante in vitro, pois foi o mais efetivo para reduzir a lipoperoxidação (TBARS) basal e induzida pelos pró-oxidantes ferro, peróxido de hidrogênio e nitroprussiato de sódio, tendo efeitos significativos a partir de 15 μM (p<0,05). O composto (5) também protegeu a glutationa da oxidação induzida por peróxido de hidrogênio, tendo efeito significativo na concentração de 150 μM (p<0,05). Este composto também foi o que teve maior atividade antioxidante total, demonstrada pela sua capacidade de remover o radical 1,1-difenil-2-picrilhidrazil (DPPH). Os compostos (1) e (4) também reduziram a lipoperoxidação basal e induzida por ferro e nitroprussiato de sódio, tendo efeitos significativos a partir de 15 μM (p<0,05). O composto (2) apresentou a maior capacidade de redução de ferro (p<0,05). A administração de escopolamina 30 min antes do treino provocou amnésia, medida como a redução na latência para descer da plataforma no teste de esquiva inibitória (p<0.05). O pré-tratamento com o composto (5) 30 min antes da escopolamina não apresentou efeito per se na latência, mas preveniu o efeito amnésico da escopolamina, na dose de 100 μmol/kg (p<0.05). Não foi observado efeito significativo da escopolamina ou do composto (5) em qualquer dos marcadores de estresse oxidativo avaliados (substâncias reativas ao ácido tiobarbitúrico, grupos tiólicos não protéicos e atividade das enzimas superóxido dismutase e catalase), sugerindo que o efeito protetor do composto (5) não está relacionado à sua atividade antioxidante. Os resultados obtidos demonstram que o composto (5) apresenta atividade antioxidante in vitro e neuroprotetora em um modelo de amnésia, sugerindo que este composto pode ser promissor para o tratamento da doença de Alzheimer. No entanto, outros estudos são necessários para elucidar os mecanismos envolvidos na ação anti-amnésica deste composto, bem como o seu efeito em outros modelos de demência.

Datura metel is a herbaceous plant found in almost all tropical parts of the world. It belongs to the family Solanaceae whose members, viz. Duboisia, Atropa, Hyoscyamus and Datura plants are known to produce tropane alkaloids- hyoscyamine and scopolamine which are most noted for their therapeutic use as anti-cholinergic agents. Since these alkaloids are produced in very low amounts in plants, alternative sources and methods of production for these alkaloids have been crucial in meeting the demands for these drugs. Endophytic fungi inhabiting a plant may have the potential to produce the same compounds as the host plants. The aim of the present study was to search for tropane alkaloid producing endophytic fungal isolates from Datura metel. Eighteen endophytic fungi were isolated from various tissues of Datura metel and screened for the presence of three tropane alkaloid biosynthetic genes- putrescine N-methyltransferase (PMT), tropinone reductase I (TRI) and hyoscyamine 6β-hydroxylase (H6H) using PCR-based screening approach. Six endophytic fungal isolates were found to possess the PMT, TR1 and H6H genes. The fungi were identified using molecular taxonomy as Col letotrichum boninense, Phomopsis sp., Fusarium solani, Col letotrichum incarnatum, Col letotrichum siamense and Col letotrichum gloeosporioides and the identity was confirmed using colony and spore morphology. The production of tropane alkaloids hyoscyamine and scopolamine by the fungi has been ascertained using various techniques like TLC, HPLC and ESI-MS/MS by comparison with the authentic reference standards. The amount of tropane alkaloids produced by all six fungi in liquid cultures was quantified using HPLC analysis. Among the six tropane alkaloid-producing fungi Col letotrichum incarnatum gave the highest yields of hyoscyamine and scopolamine which were 3.906 mg/L and 4.13 mg/L, respectively. With an aim to characterize the tropane alkaloid biosynthetic genes in these fungi, the PMT gene was isolated from five of the endophytic fungi- Col letotrichum boni-nense, Fusarium solani, Col letotrichum incarnatum, Col letotrichum siamense and Col-letotrichum gloeosporioides for the first time and the sequence analysis showed high ho-mology (98%) to the Datura metel PMT cDNA. The gene was found to be devoid of introns in the fungi. Further phylogenetic analysis of the full length PMT sequence from the fungi strongly supports the hypothesis of horizontal gene transfer between the host plant and endophytic fungi. For further in detail characterization of fungal PMT, the Col letotrichum boninense PMT gene was taken as a representative. CbPMT gene was cloned in pRSET A expres-sion vector and heterologously expressed in E. coli and biochemically characterized. For optimal yield of soluble protein upon heterologous expression different conditions such as IPTG concentration, temperature and time post induction were optimized. Optimal yield was obtained by inducing the culture by 0.25 mM IPTG once it had reached and O.D. of 0.6 and incubating at 37◦ C for 3 h. The recombinant CbPMT enzyme expressed as histidine tagged fusion protein was purified using Ni-NTA affinity chromatography. Gel elution studies were carried out to determine molecular weight of the protein and it was found that the protein exists as a homodimer in solution with some amount also present as a monomer. Catalytic activity of the purified recombinant enzyme was studied for its dependence on both substrates putrescine as well as S-adenosylmethionine (SAM). The Km and Vmax values for putrescine were found to be 464 µM and 18.55 nkat/mg, respectively, while those for S-adenosylmethionine were found to be 628 µM and 18.63 nkat/mg, respectively. Optimum temperature for activity was found to be 37◦ C and optimum pH range was found to be 8-9. Fluorescence spectroscopy was used to study the binding affinity of both the sub-strates to the enzyme. Fluorescence quenching data for each substrate was analysed by using a nonlinear regression curve fit and Kd values were found to be 0.309 mM for pu-trescine and 0.118 mM for SAM, respectively. Circular dichroism spectrum of the enzyme indicated a pattern typical for alpha helix in the secondary structure. Binding of either substrate led to increase in ellipticity of the protein. Fluorescence quenching studies with collisional quenchers- acrylamide, potassium iodide, and cesium chloride indicated that the native protein is folded in a conformation that allows tryptophan residues to be acces-sible for quenching. The fraction of tryptophan residues (fa ) accessible for quenching by acrylamide (1.06) was found to be higher than that for potassium iodide (0.54) while that cesium ions was the least (0.38). The neutral quencher acrylamide could access all the tryptophans meaning that none of tryptophans are completely buried inside hydrophobic cores. the differential accessibility to the charged quenchers, however, indicates that more of the tryptophans are surrounded by positively charged amino acids. The unfolding of the protein was studied with the aid of chaotropic agents guanidine-HCl and urea and thermodynamic parameters were determined. The denaturant m-values were found to be 2.313 kcal/mol/M for Gdn-HCl and 2.345 kcal/mol/M for urea respectively. The free energy of unfolding was estimated to be 2.635 kcal/mol for Gdn-HCl and 4.630 kcal/mol for urea. Since no reports are available about the thermodynamics of folding and unfolding of PMT from any plant source, this study contributes towards the understanding of protein stability. Although a lot of reports are available on the biochemical characterization of PMT from different plant sources, the crystal structure of PMT is not yet available. In the current work, homology based modelling studies on CbPMT were carried out to get some idea about the protein tertiary structure. Homology based modelling studies showed that a significant amount of protein is present as α-helices which are present on the surface while the β-sheets are present in the interior of the protein. Each monomer of the protein is capable of binding both the substrates and hence the dimerization property of the enzyme could be a purely structural one leading to more stability and solubility of the protein. In conclusion, this study has shown for the first time that endophytic fungi have significant potential to be used for tropane alkaloid production and six such fungal strains have been identified. Although the production of tropane alkaloids by endophytic fungi is not very high, it can be scaled up by over-expressing the biosynthetic gene putrescine N-methyltransferase in the highest producer- Col letotrichum incarnatum to further increase the yield. These endophytic fungi have significant potential to be applied in fermentation technology to meet the demands for these drugs economically.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / Memory is considered to be a process that has several stages, including acquisition, consolidation and retrieval. Memory impairment occurs when important synapses are modified. Alzheimer s disease (DA) is the most common cause of dementia. DA is characterized by cognitive damage, accumulation of the pathogenic amyloid-β (Aβ) peptide, and cholinergic dysfunction. Moreover, oxidative stress is associated with DA. Therapies used for dementia are still palliative rather than curative. Consequently, new therapies are urgently required. Biological effects of tellurium compounds have been studied, leading to a set of interesting and promising applications. Accordingly, 2-phenylethinyl-butyltellurium (PEBT), an organotellurium compound, has been reported as antioxidant. The purpose of this study was to characterize PEBT as a promising alternative for memory improvement and prevention of cognitive deficits, using experimental models of DA in mice. Initially, the present study was conducted to evaluate the effect of a single oral administration (p.o.) of PEBT at a dose of 10 mg/kg on memory, employing the step-down inhibitory avoidance task. PEBT administered 1 h before training, immediately after training or 1 h before the test session of the step-down inhibitory avoidance task increased the step-down latency time in comparison to the control mice, improving acquisition, consolidation, and retrieval of memory, respectively. The glutamate uptake, but not glutamate release, by cerebral cortex and hippocampal slices of mice was inhibited after 1 h of treatment with PEBT. After 24 h of PEBT exposure, the inhibition of cerebral cortex glutamate uptake disappeared. The improvement of memory by PEBT seems most likely to be mediated through an interaction with the amino acid transporters of the glutamatergic system. Thereafter, a subchronic PEBT treatment (1 mg/kg, p.o., for 10 days) after injection of Aβ(25-35) (3 nmol/3 μl/per site, intracerebroventricular) reversed Aβ-induced learning and memory deficits in the Morris water maze and step-down inhibitory avoidance tasks. In addition, PEBT (10 mg/kg, p.o.), administered 30 min before scopolamine (1 mg/kg, intraperitoneal), ameliorated memory deficit induced by this amnesic agent in the Morris water maze. Further, scopolamine was given 30 min before training and test or immediately post-training of step-down inhibitory avoidance task, inducing damage on acquisition, retrieval, and consolidation of memory, respectively. PEBT, administered 30 min before scopolamine, improved consolidation and retrieval stages, but not acquisition. General locomotor and exploratory activities, evaluated in the open-field test, were similar in all mice. Finally, the antiapoptotic effect of PEBT was evaluated. Human retinal pigment epithelial cells (ARPE-19 cell line) were exposed to in vitro oxidative stress by 10 ng/ml tumor necrosis factor-α and 600 μM H2O2. One hour PEBT incubation at concentrations of 7.5 and 10 μM attenuated the apoptosis induced by oxidative stress. This effect lasted up to 6 hours after oxidative stress induction. PEBT (5 and 10 μM) inhibited oxidative stress-induced poly (ADP-ribose) polymerase (PARP) cleavage and restored extracellular-signal-related kinase (ERK) phosphorylation decreased by oxidative stress. The protective mechanism exerted by PEBT against oxidative stress may involve PARP cleavage, regulation of ERK pathway, as well as its known antioxidant properties. In conclusion, the finds of the present thesis point out the ameliorative effect of PEBT on memory stages (acquisition, consolidation and retrieval). Likewise, PEBT improved memory impairment in mice. These effects seem to be due to strengthen the physiological glutamatergic tonus by PEBT and the antiapoptotic effect of PEBT. Therefore, PEBT could be considered a candidate for the prevention of memory deficits such as those observed in DA. / memória inclui pelo menos três tipos de processamento relacionados entre si: aquisição, consolidação e evocação. A memória é afetada quando as sinapses encarregadas de fazer ou evocar memórias encontram-se alteradas. A doença de Alzheimer (DA) é a causa mais comum de demência. A DA é caracterizada por danos cognitivos, acúmulo de peptídeo β-amiloide (Aβ) e disfunção colinérgica. Além disso, o estresse oxidativo está associado à DA. Uma vez que ainda não há cura para a DA e as terapias atuais são apenas paliativas, torna-se importante a busca de novos compostos para melhorar danos cognitivos. Com o estudo dos efeitos biológicos de compostos de telúrio, muitas aplicações estão sendo descobertas. Neste sentido, o composto orgânico de telúrio 2-feniletinil-butiltelúrio (PEBT) apresenta efeito antioxidante. O objetivo deste estudo foi caracterizar o PEBT como uma alternativa promissora para a melhora e prevenção de danos cognitivos, usando modelos experimentais da DA em camundongos. Primeiramente, avaliou-se o efeito de uma única dose oral (p.o) de PEBT (10 mg/kg) na memória, utilizando a tarefa da esquiva inibitória. O tratamento com PEBT 1 h antes do treino, imediatamente após o treino ou 1 h antes do teste da esquiva inibitória aumentou a latência comparada com os animais controles, melhorando a aquisição, consolidação e evocação da memória, respectivamente. A captação de glutamato, mas não a liberação deste neurotrasmissor, foi inibida em córtex e hipocampo de camundongos após 1 h de tratamento com PEBT. Após 24 h, a inibição da captação de glutamato no córtex não foi mais evidenciada. A melhora da memória causada pelo PEBT parece ser mediada através da interação com os transportadores de glutamato. Além disso, o tratamento subcrônico com PEBT (1 mg/kg, p.o., por 10 dias) após a injeção de Aβ(25-35) (3 nmol/3 μl/per site, intracerebroventricular) reverteu o prejuízo no aprendizado e na memória causados por Aβ nas tarefas do labirinto aquático de Morris e na esquiva inibitória. O PEBT (10 mg/kg, p.o.), adminstrado 30 min antes da escopolamina (1 mg/kg, intraperitoneal), também protegeu do dano de memória causado por este agente anticolinérgico no labirinto aquático de Morris. Quando a escopolamina foi administrada 30 min antes do treino ou teste, ou imediatamente após o treino da esquiva inibitória houve dano na aquisição, evocação e consolidação da memória, respectivamente. O PEBT, administrado 30 min antes da escopolamina, protegeu do dano na consolidação e evocação da memória, mas não na aquisição. Não houve diferença nas atividades locomotora e exploratória dos animais tratados com o PEBT no teste do campo aberto. Finalmente, o efeito antiapoptótico do PEBT foi avaliado. Células do epitélio pigmentado da retina humana (linhagem ARPE-19) foram expostas ao estresse oxidativo induzido pelo fator de necrose tumoral-α (10 ng/ml) e H2O2 (600 μM). O PEBT (7.5 e 10 μM), quando pré-incubado por 1 h, protegeu contra a apoptose induzida pelo estresse oxidativo e este efeito permaneceu até 6 h após a indução. O PEBT (5 e 10 μM) inibiu a clivagem da poli(ADP-ribose) polimerase (PARP) induzida por estresse oxidativo e, também, restaurou a fosforilação da quinase regulada por sinal extracelular (ERK). O efeito protetor do PEBT contra o estresse oxidativo parece envolver a clivagem da PARP e a regulação da fosforilaçao de ERK, além de sua atividade antioxidante. Nesse sentido, os resultados apresentados nesta tese destacam o efeito do PEBT na melhora das três fases da memória, bem como em modelos de dano cognitivos em camundongos. Estes resultados parecem estar relacionados ao aumento do tônus glutamatérgico causado pelo PEBT e seu efeito antiapoptótico. Assim sendo, estes dados sugerem que o PEBT poderá, futuramente, ser considerado candidato para a prevenção de danos de memória, como aqueles observados na DA.

Made available in DSpace on 2015-07-22T20:50:21Z (GMT). No. of bitstreams: 0 Previous issue date: 2011-02-21 / Diversos autores sugerem que a sensibilização comportamental, caracterizada pelo aumento da atividade psicomotora em resposta à administração repetida de drogas psicoativas, parece desempenhar um papel fundamental no desenvolvimento de abuso e dependência, aumentando a propriedade reforçadora destas substâncias. Animais que desenvolvem sensibilização ao etanol apresentam diferenças na densidade de receptores de alguns neurotransmissores e também na resposta à administração de agonistas e antagonistas destes receptores. A sensibilização comportamental é um fenômeno complexo que envolve diferentes fatores, sendo afetada pelo ambiente, possuindo um componente de aprendizagem. Para avaliar a influência da capacidade de aprendizagem no processo de sensibilização ao efeito estimulante do etanol, no presente estudo comparamos o desempenho de dois grupos de animais com diferentes níveis de sensibilização (alta e baixa) em dois tipos de tarefas (apetitiva e aversiva). Também avaliamos a influência de uma droga amnésica (escopolamina) no desenvolvimento e expressão da sensibilização. Foi observado que animais com diferentes níveis de sensibilização não diferiram quanto à capacidade de aprendizagem após o tratamento crônico com etanol, independentemente do tipo de tarefa. A escopolamina quando administrada no hipocampo dorsal simultaneamente ao tratamento crônico com etanol não alterou o desenvolvimento da sensibilização. Porém, quando administrada por via subcutânea, provocou aumento mais acentuado nos níveis de atividade locomotora em animais que já haviam desenvolvido alta sensibilização do que nos animais que haviam desenvolvido baixa sensibilização ou no grupo controle. Este fenômeno não foi observado quando a administração de escopolamina foi realizada diretamente no núcleo accumbens, e quando administrada em combinação com etanol, foi capaz de bloquear a sensibilização. Estes dados sugerem que o sistema colinérgico atue como um neuromodulador do processo de sensibilização. Porém, parece agir de maneira diferente dependendo do nível de sensibilização desenvolvido pelo animal. / Several authors suggest that behavioral sensitization, characterized as psychomotor activity increase in response to psychoactive drugs repeated administration, seems to play a fundamental role in the development of abuse and dependence, increasing the reinforcement property of these substances. Animals that develop sensitization to ethanol differ regarding the binding to some neurotransmitter receptors and also differ regarding the response to the administration of agonists and antagonists of these receptors. Behavioral sensitization is a complex phenomenon that involves different factors, being affected by environment and learning. To evaluate the influence of learning capacity in the sensitization process, in the present study we compared the performance of two groups of mice that presented different levels of sensitization (high and low) in two different learning tasks (appetitive and aversive). We also evaluated the influence of an amnestic drug (scopolamine) in the development and expression of sensitization. It was observed that mice with different levels of sensitization did not differ regarding their learning capacity after chronic treatment with ethanol, in both tasks. Scopolamine, when administered in the dorsal hippocampus simultaneously with ethanol treatment, did not alter the sensitization development. However, when administered subcutaneously it induced higher levels of locomotor activity in those animals that had already developed high sensitization than in low sensitized mice or in the control group. This phenomenon was not observed when scopolamine was administered directly in the nucleus accumbens. When administered in combination with ethanol, it blocked the sensitization. These data suggest that the cholinergic system acts as a neuromodulator in the sensitization process. However, the cholinergic system seems to act in different ways depending on the level of sensitization developed by the animal. / TEDE / BV UNIFESP: Teses e dissertações

No description available.